{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:12:03Z","timestamp":1794643923417,"version":"4.9.1"},"reference-count":158,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014935","name":"BioCryst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN266200700005C"],"award-info":[{"award-number":["HHSN266200700005C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.antiviral.2013.08.023","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T12:32:23Z","timestamp":1378297943000},"page":"520-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance"],"prefix":"10.1016","volume":"100","author":[{"given":"Andrew J.","family":"Burnham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Baranovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Govorkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.08.023_b0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/1471-2334-10-308","article-title":"Co-infection of Influenza B and Streptococci causing severe pneumonia and septic shock in healthy women","volume":"10","author":"Aebi","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-2659.2011.00304.x","article-title":"Influenza neuraminidase","volume":"6","author":"Air","year":"2012","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.antiviral.2013.08.023_b0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/135965350701200S04.1","article-title":"Influenza virus susceptibility and resistance to oseltamivir","volume":"12","author":"Aoki","year":"2007","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2013.08.023_b0020","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm0002679","article-title":"BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design","volume":"43","author":"Babu","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.08.023_b0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2005.10.002","article-title":"Anti-influenza virus activity of peramivir in mice with single intramuscular injection","volume":"69","author":"Bantia","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.023_b0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/viro.1999.0058","article-title":"In vitro selection and characterisation of influenza B\/Beijing\/1\/87 isolates with altered susceptibility to zanamivir","volume":"265","author":"Barnett","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.08.023_b0035","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2165\/11641110-000000000-00000","article-title":"The coming era of quadrivalent human influenza vaccines: who will benefit?","volume":"72","author":"Barr","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2013.08.023_b0040","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/JCM.05069-11","article-title":"Detection of an influenza B virus strain with reduced susceptibility to neuraminidase inhibitor drugs","volume":"49","author":"Bastien","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(03)00011-1","article-title":"A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding","volume":"59","author":"Baum","year":"2003","journal-title":"Antiviral Res."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2013.08.023_b0050","doi-asserted-by":"crossref","first-page":"D45","DOI":"10.1016\/j.vaccine.2010.08.028","article-title":"The need for quadrivalent vaccine against seasonal influenza","volume":"28","author":"Belshe","year":"2010","journal-title":"Vaccine"},{"issue":"Pt 11","key":"10.1016\/j.antiviral.2013.08.023_b0055","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1099\/0022-1317-77-11-2689","article-title":"The NB protein is an integral component of the membrane of influenza B virus","volume":"77","author":"Betakova","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3201\/eid1903.120965","article-title":"Recurring influenza B virus infections in seals","volume":"19","author":"Bodewes","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.1460-2075.1992.tb05026.x","article-title":"The 2.2A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid","volume":"11","author":"Burmeister","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2013.08.023_b0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/abio.2000.4517","article-title":"Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir","volume":"280","author":"Buxton","year":"2000","journal-title":"Anal. Biochem."},{"issue":"Suppl 1","key":"10.1016\/j.antiviral.2013.08.023_b0075","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1093\/infdis\/jis534","article-title":"Characteristics of patients with influenza-like illness, severe acture respiratory illness, and laboratory-confirmed influenza at a major children\u2019s hospital in Angola, 2009\u20132011","volume":"206","author":"Cardoso","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/INF.0b013e3181ff863b","article-title":"Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer","volume":"30","author":"Carr","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2013.08.023_b0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1358\/dot.2010.46.6.1459659","article-title":"Peramivir and its use in H1N1 influenza","volume":"46","author":"Castillo","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.antiviral.2013.08.023_b0090","unstructured":"CDC, 2013a. Influenza National and Regional Level Graphs and Data. Available from: <http:\/\/gis.cdc.gov\/grasp\/fluview\/fluportaldashboard.html>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0095","unstructured":"CDC, 2013b. Influenza-Associated Pediatric Mortality. Available from: <http:\/\/gis.cdc.gov\/GRASP\/Fluview\/PedFluDeath.html>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.antiviral.2004.04.004","article-title":"In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors","volume":"63","author":"Cheam","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.023_b0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00705-006-0852-6","article-title":"Exploration of the emergence of the Victoria lineage of influenza B virus","volume":"152","author":"Chen","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00239-008-9119-z","article-title":"The evolutionary dynamics of human influenza B virus","volume":"66","author":"Chen","year":"2008","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1179\/1465328111Y.0000000012","article-title":"Complicated features in a young child with influenza B virus pneumonia and co-infection with Stenotrophomonas maltophilia","volume":"31","author":"Chen","year":"2011","journal-title":"Ann. Trop. Paediatr."},{"key":"10.1016\/j.antiviral.2013.08.023_b0120","doi-asserted-by":"crossref","first-page":"e49224","DOI":"10.1371\/journal.pone.0049224","article-title":"The evolutionary pattern of glycosylation sites in influenza virus (H5N1) hemagglutinin and neuraminidase","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2013.08.023_b0125","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/INF.0b013e31816be008","article-title":"Clinical features of children infected with different strains of influenza B in southern Taiwan","volume":"27","author":"Chi","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2013.08.023_b0130","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1086\/514179","article-title":"Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture","volume":"176","author":"Colacino","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0800","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/303041a0","article-title":"Structure of the catalytic and antigenic sites in influenza virus neuraminidase","volume":"303","author":"Colman","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.08.023_b0135","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/jvi.67.6.2972-2980.1993","article-title":"Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase","volume":"67","author":"Colman","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0140","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/pro.5560031007","article-title":"Influenza virus neuraminidase: structure, antibodies, and inhibitors","volume":"3","author":"Colman","year":"1994","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2013.08.023_b0145","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.326.7401.1235","article-title":"Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials","volume":"326","author":"Cooper","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2013.08.023_b0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00006454-199706000-00018","article-title":"Myocarditis with influenza B infection","volume":"16","author":"Craver","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2013.08.023_b0155","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-adamantanamine (Amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.08.023_b0160","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.01417-09","article-title":"Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing","volume":"54","author":"Deyde","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/fampra\/cms059","article-title":"Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials","volume":"30","author":"Ebell","year":"2013","journal-title":"Fam. Pract."},{"key":"10.1016\/j.antiviral.2013.08.023_b0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcv.2007.10.019","article-title":"Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors","volume":"41","author":"Escuret","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0175","unstructured":"EuroFlu, 2013. EuroFlu Electronic Bulletin. Available from: <http:\/\/www.euroflu.org>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0180","unstructured":"FDA, 2013a. Approved Products \u2013 Fluzone Quadrivalent. Available from: <http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm356091.htm>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0185","unstructured":"FDA, 2013b. Approved Products \u2013 FluMist Quadrivalent. Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm293952.htm."},{"key":"10.1016\/j.antiviral.2013.08.023_b0190","unstructured":"FDA, 2013c. Approved Products \u2013 Fluarix Quadrivalent. Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm342391.htm."},{"key":"10.1016\/j.antiviral.2013.08.023_b0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.92.2392.405","article-title":"A new type of virus from epidemic influenza","volume":"92","author":"Francis","year":"1940","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.08.023_b0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s15010-010-0013-4","article-title":"Lethal influenza B myocarditis in a child and review of the literature for pediatric age groups","volume":"38","author":"Frank","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2013.08.023_b0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbrc.2012.10.095","article-title":"A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs","volume":"429","author":"Fujisaki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2013.08.023_b0210","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/infdis\/jis776","article-title":"A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility\u2013North Carolina and South Carolina, 2010\u20132011","volume":"207","author":"Garg","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0215","unstructured":"Genentech USA, I., 2012. Tamiflu\u00ae (oseltamivir phosphate) Prescribing Information. In: Genentech (Ed.), South San Francisco, CA."},{"key":"10.1016\/j.antiviral.2013.08.023_b0220","unstructured":"GlaxoSmithKline, 2013. Relenza (Zanamivir for Inhalation) prescribing information, us.gsk.com\/products\/assets\/us_relenza.pdf"},{"key":"10.1016\/j.antiviral.2013.08.023_b0225","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.2105\/AJPH.2012.301137","article-title":"The burden of influenza B: a structured literature review","volume":"103","author":"Glezen","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.antiviral.2013.08.023_b0230","doi-asserted-by":"crossref","first-page":"13468","DOI":"10.1073\/pnas.1107032108","article-title":"Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus","volume":"108","author":"Guan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.08.023_b0235","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/314440","article-title":"Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus","volume":"178","author":"Gubareva","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0240","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jinf.2012.07.004","article-title":"Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave","volume":"65","author":"Gutierrez-Pizarraya","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2013.08.023_b0245","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1086\/598513","article-title":"Seasonal influenza in adults and children\u2013diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America","volume":"48","author":"Harper","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0250","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jama.297.13.1435","article-title":"Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors","volume":"297","author":"Hatakeyama","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.08.023_b0255","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1469-0691.2010.03313.x","article-title":"In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors","volume":"17","author":"Hatakeyama","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2013.08.023_b0260","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1128\/JVI.77.10.6050-6054.2003","article-title":"The NB protein of influenza B virus is not necessary for virus replication in vitro","volume":"77","author":"Hatta","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0265","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1098\/rstb.2001.0999","article-title":"The evolution of human influenza viruses","volume":"356","author":"Hay","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.antiviral.2013.08.023_b0270","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group","volume":"337","author":"Hayden","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.08.023_b0275","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199910283411802","article-title":"Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza","volume":"341","author":"Hayden","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.08.023_b0280","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.08.023_b0285","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/135965350000500305","article-title":"Oral oseltamivir in human experimental influenza B infection","volume":"5","author":"Hayden","year":"2000","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2013.08.023_b0290","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00003088-199937060-00003","article-title":"Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802","volume":"37","author":"He","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2013.08.023_b0295","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/656408","article-title":"Early oseltamivir treatment of influenza in children 1\u20133 years of age: a randomized controlled trial","volume":"51","author":"Heinonen","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0300","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1128\/JCM.00682-12","article-title":"Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient","volume":"50","author":"Higgins","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0305","doi-asserted-by":"crossref","first-page":"834181","DOI":"10.1155\/2012\/834181","article-title":"Clinical effectiveness of peramivir in comparison with other neuraminidase inhibitors in pediatric influenza patients","volume":"2012","author":"Hikita","year":"2012","journal-title":"Int. J. Pediatr."},{"key":"10.1016\/j.antiviral.2013.08.023_b0310","unstructured":"Hoffmann-La Roche, I., Nutley, New Jersey, 2007. Pediatric Advisory Committee Breifing Document for Tamiflu. Available from: <http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007-4325b_02_15_Sponsor%20Background%20Package%20Roche.pdf>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0315","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI101140","article-title":"Four recent influenza epidemics: an experimental study","volume":"19","author":"Horsfall","year":"1940","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2013.08.023_b0320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2003.11.008","article-title":"Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir","volume":"62","author":"Hurt","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.023_b0325","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virusres.2004.02.035","article-title":"Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs","volume":"103","author":"Hurt","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2013.08.023_b0330","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.50.5.1872-1874.2006","article-title":"Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient","volume":"50","author":"Hurt","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0335","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/0091270009356297","article-title":"Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers","volume":"50","author":"Ishizuka","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0340","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/500465","article-title":"Recovery of drug-resistant influenza virus from immunocompromised patients: a case series","volume":"193","author":"Ison","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0345","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkh528","article-title":"Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations","volume":"55","author":"Jackson","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.026187-0","article-title":"Molecular studies of influenza B virus in the reverse genetics era","volume":"92","author":"Jackson","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0355","doi-asserted-by":"crossref","unstructured":"Jefferson, T., Jones, M.A., Doshi, P., Del Mar, C.B., Heneghan, C.J., Hama, R., Thompson, M.J., 2012. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. The, Cochrane database of systematic reviews 1, CD008965.","DOI":"10.1002\/14651858.CD008965.pub3"},{"key":"10.1016\/j.antiviral.2013.08.023_b0360","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/505868","article-title":"A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003\u20132004 and 2004\u20132005 influenza seasons","volume":"43","author":"Kawai","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0365","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jinf.2007.05.176","article-title":"Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir","volume":"55","author":"Kawai","year":"2007","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2013.08.023_b0370","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jinf.2007.09.002","article-title":"A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B","volume":"56","author":"Kawai","year":"2008","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2013.08.023_b0375","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/vim.2009.0045","article-title":"Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus","volume":"22","author":"Kim","year":"2009","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0380","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/AAC.00412-11","article-title":"Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques","volume":"55","author":"Kitano","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0385","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/172.5.1352","article-title":"Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis","volume":"172","author":"Klimov","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0390","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s15010-003-3091-8","article-title":"Influenza B pneumonia with Staphylococcus aureus superinfection associated with parvovirus B19 and concomitant agranulocytosis","volume":"31","author":"Krell","year":"2003","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2013.08.023_b0395","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10156-011-0292-4","article-title":"High and continuous exposure of laninamivir, an anti-influenza drug, may work suppressively to generate low-susceptibility mutants in animals","volume":"18","author":"Kubo","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0400","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1128\/jvi.67.11.6667-6673.1993","article-title":"Glycosylation of neuraminidase determines the neurovirulence of influenza A\/WSN\/33 virus","volume":"67","author":"Li","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0405","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcv.2007.11.026","article-title":"Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan","volume":"42","author":"Li","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0410","first-page":"242","article-title":"Influenza B virus associated pneumonia: report of one case","volume":"45","author":"Lu","year":"2004","journal-title":"Acta Paediatr. Taiwan"},{"key":"10.1016\/j.antiviral.2013.08.023_b0415","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jmv.20156","article-title":"Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community","volume":"74","author":"Matsuzaki","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0420","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1128\/JVI.78.23.12817-12828.2004","article-title":"Multiple genotypes of influenza B virus circulated between 1979 and 2003","volume":"78","author":"McCullers","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0425","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.virol.2005.03.028","article-title":"A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence","volume":"336","author":"McCullers","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.08.023_b0430","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jir865","article-title":"Fatal influenza B infections: time to reexamine influenza research priorities","volume":"205","author":"McCullers","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0435","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/AAC.47.7.2264-2272.2003","article-title":"Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir","volume":"47","author":"McKimm-Breschkin","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0440","doi-asserted-by":"crossref","first-page":"e60348","DOI":"10.1371\/journal.pone.0060348","article-title":"The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews","volume":"8","author":"Michiels","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2013.08.023_b0445","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/AAC.49.11.4515-4520.2005","article-title":"Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors","volume":"49","author":"Mishin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.282.1.31","article-title":"Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial","volume":"282","author":"Monto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.08.023_b0455","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0460","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.4076\/1757-1626-2-6809","article-title":"Myocarditis mimicking acute coronary syndrome following influenza B virus infection: a case report","volume":"2","author":"Muneuchi","year":"2009","journal-title":"Cases J."},{"key":"10.1016\/j.antiviral.2013.08.023_b0465","doi-asserted-by":"crossref","first-page":"647528","DOI":"10.1155\/2011\/647528","article-title":"Acute respiratory distress syndrome caused by influenza B virus infection in a patient with diffuse large B-cell lymphoma","volume":"2011","author":"Namendys-Silva","year":"2011","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.antiviral.2013.08.023_b0470","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1086\/368184","article-title":"Encephalitis associated with influenza B virus infection in 2 children and a review of the literature","volume":"36","author":"Newland","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0475","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2013.08.023_b0480","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.antiviral.2012.01.006","article-title":"Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States","volume":"93","author":"Nguyen","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.023_b0485","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2013.08.023_b0490","unstructured":"NIID, 2013. Flash report of influenza virus. Available from: <http:\/\/www.nih.go.jp\/niid\/en\/iasr-inf-e.html>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0495","unstructured":"NIMR, 2013. WHO Influenza Centre \u2013 Annual and interim reports | MRC National Institute for Medical Research, London. Available from: <http:\/\/www.nimr.mrc.ac.uk\/who-influenza-centre\/annual-and-interim-reports\/>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0500","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.80.7.3675-3678.2006","article-title":"Comparison of the mutation rates of human influenza A and B viruses","volume":"80","author":"Nobusawa","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0505","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1021\/jm100621s","article-title":"Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses","volume":"53","author":"Oakley","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.08.023_b0510","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1348-0421.2002.tb02746.x","article-title":"Serological evidence of transmission of human influenza A and B viruses to Caspian seals (Phoca caspica)","volume":"46","author":"Ohishi","year":"2002","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0515","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3390\/v2102269","article-title":"Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective","volume":"2","author":"Okomo-Adhiambo","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2013.08.023_b0790","doi-asserted-by":"crossref","unstructured":"Okomo-Adhiambo, M., Sleeman, K., Lysen, C., Nguyen, H.T., Xu, X., Li, Y., Klimov, A.I., Gubareva, L.V., 2013. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. Influenza and other respiratory viruses.","DOI":"10.1111\/irv.12113"},{"key":"10.1016\/j.antiviral.2013.08.023_b0525","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.288.5468.1051","article-title":"Influenza B virus in seals","volume":"288","author":"Osterhaus","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.08.023_b0530","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/infdis\/jir861","article-title":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection","volume":"205","author":"Paddock","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0535","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/345909","article-title":"Influenza A and B virus infections in children","volume":"36","author":"Peltola","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0540","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1503\/cmaj.111055","article-title":"Targeting influenza vaccinations of children","volume":"183","author":"Peltola","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.antiviral.2013.08.023_b0545","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1128\/JVI.06645-11","article-title":"Transmission of influenza B viruses in the guinea pig","volume":"86","author":"Pica","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0550","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-d-N-acetylneuraminate) substrate","volume":"94","author":"Potier","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2013.08.023_b0555","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jcv.2013.01.009","article-title":"Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe","volume":"57","author":"Pozo","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0560","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jmv.20225","article-title":"Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001\u201302, 2002\u201303, and 2003\u201304 seasons","volume":"74","author":"Puzelli","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0565","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2011.12.098","article-title":"Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine","volume":"30","author":"Reed","year":"2012","journal-title":"Vaccine"},{"issue":"Pt 10","key":"10.1016\/j.antiviral.2013.08.023_b0570","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1099\/0022-1317-73-10-2737","article-title":"Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus","volume":"73","author":"Rota","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0575","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.meegid.2011.05.022","article-title":"Surveillance and molecular characterization of human influenza B viruses during 2006\u20132010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India","volume":"11","author":"Roy","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0580","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.08.023_b0585","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1292\/jvms.59.923","article-title":"Loss of glycosylation at Asn144 alters the substrate preference of the N8 influenza A virus neuraminidase","volume":"59","author":"Saito","year":"1997","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.antiviral.2013.08.023_b0590","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.023_b0595","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1620\/tjem.214.113","article-title":"Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan","volume":"214","author":"Sato","year":"2008","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.antiviral.2013.08.023_b0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2002.1719","article-title":"Reappearance and global spread of variants of influenza B\/Victoria\/2\/87 lineage viruses in the 2000\u20132001 and 2001\u20132002 seasons","volume":"303","author":"Shaw","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.08.023_b0605","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/eri.11.174","article-title":"Peramivir for the treatment of influenza","volume":"10","author":"Shetty","year":"2012","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.antiviral.2013.08.023_b0610","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0615","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.antiviral.2009.10.022","article-title":"Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing","volume":"85","author":"Sheu","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.023_b0620","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/AAC.45.3.749-757.2001","article-title":"In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201","volume":"45","author":"Sidwell","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0625","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3201\/eid1711.110787","article-title":"Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010\u201311","volume":"17","author":"Sleeman","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0630","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1006\/viro.1995.0078","article-title":"Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en","volume":"214","author":"Staschke","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.08.023_b0635","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1073\/pnas.84.9.2703","article-title":"Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs","volume":"84","author":"Stoeckle","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.08.023_b0640","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/509925","article-title":"Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children","volume":"44","author":"Sugaya","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0645","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/589748","article-title":"Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children","volume":"47","author":"Sugaya","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0650","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/AAC.01755-09","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection","volume":"54","author":"Sugaya","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0655","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.00132-11","article-title":"Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection","volume":"56","author":"Sugaya","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0660","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s002329900037","article-title":"Ion channels formed by NB, an influenza B virus protein","volume":"150","author":"Sunstrom","year":"1996","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0665","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.PCC.0000123555.10869.09","article-title":"Severe influenza B myocarditis and myositis","volume":"5","author":"Tabbutt","year":"2004","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2013.08.023_b0670","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3851\/IMP1194","article-title":"Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996\u20132007","volume":"14","author":"Tashiro","year":"2009","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2013.08.023_b0675","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/jm9703754","article-title":"Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B","volume":"41","author":"Taylor","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.08.023_b0680","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.08.023_b0685","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.08.023_b0690","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/prot.340140302","article-title":"The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor","volume":"14","author":"Varghese","year":"1992","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2013.08.023_b0695","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.08.023_b0700","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1875-9572(09)60033-4","article-title":"Clinical and laboratory analysis of influenza B infection in children in Taichung, Taiwan during the 2006\u20132007 flu season","volume":"50","author":"Wang","year":"2009","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0705","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.antiviral.2012.12.013","article-title":"Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir","volume":"97","author":"Wang","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.023_b0710","doi-asserted-by":"crossref","unstructured":"Wang, K., Shun-Shin, M., Gill, P., Perera, R., Harnden, A., 2012. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). The, Cochrane database of systematic reviews 4, CD002744.","DOI":"10.1002\/14651858.CD002744.pub4"},{"key":"10.1016\/j.antiviral.2013.08.023_b0715","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/656802","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial","volume":"51","author":"Watanabe","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0720","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/JCM.41.2.742-750.2003","article-title":"Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network","volume":"41","author":"Wetherall","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0725","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2013.08.023_b0730","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/cis1220","article-title":"Global assessment of resistance to neuraminidase inhibitors, 2008\u20132011: the Influenza Resistance Information Study (IRIS)","volume":"56","author":"Whitley","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0735","first-page":"149","article-title":"Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003\u20132006 influenza seasons","volume":"82","author":"WHO","year":"2007","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2013.08.023_b0740","first-page":"222","article-title":"Review of the 2010\u20132011 winter influenza season, northern hemisphere","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2013.08.023_b0745","unstructured":"WHO, 2012a. WHO information for molecular diagnosis of influenza virus in humans \u2013 update. Available from: <http:\/\/www.who.int\/influenza\/gisrs_laboratory\/molecular_diagnosis\/en\/>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0750","unstructured":"WHO, 2012b. Antiviral-resistant B viruses with a novel mutation detected by antiviral resistance surveillance in Japan. Available from: <http:\/\/www.wpro.who.int\/emerging_diseases\/meetings\/docs\/AntiviralResistantBVirusesinJapan.pdf>."},{"key":"10.1016\/j.antiviral.2013.08.023_b0755","first-page":"101","article-title":"Recommended composition of influenza virus vaccines for use in the 2013\u20132014 northern hemisphere influenza season","volume":"88","author":"WHO","year":"2013","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2013.08.023_b0760","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.spid.2006.08.004","article-title":"The use of inactivated influenza vaccine in children","volume":"17","author":"Wright","year":"2006","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.08.023_b0795","series-title":"Fields Virology","first-page":"1691","article-title":"Orthomyxoviruses","author":"Wright","year":"2006"},{"key":"10.1016\/j.antiviral.2013.08.023_b0770","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0042-6822(88)90238-3","article-title":"Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses","volume":"163","author":"Yamashita","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.08.023_b0775","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.00333-08","article-title":"CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity","volume":"53","author":"Yamashita","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.023_b0780","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.jp.7211802","article-title":"Fatal influenza B virus pneumonia in a preterm neonate: case report and review of the literature","volume":"27","author":"Yusuf","year":"2007","journal-title":"J. Perinatol."},{"key":"10.1016\/j.antiviral.2013.08.023_b0785","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0166-3542(01)00124-3","article-title":"Position statement: global neuraminidase inhibitor susceptibility network","volume":"49","author":"Zambon","year":"2001","journal-title":"Antiviral Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421300243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421300243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:23Z","timestamp":1759062383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421300243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":158,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S016635421300243X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.08.023","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}